Jushi Holdings Announces First Settlement in Ongoing Pennsylvania Hemp‑Derived THC Litigation
On March 25, 2026, Jushi Holdings Inc. (CSE: JUSH; OTCQX: JUSHF) disclosed that its subsidiaries Agape Total Health Care Inc., Franklin Bioscience – Penn LLC, and Franklin Bioscience – SE LLC have entered into a Settlement Agreement and Mutual Release with Revelry Supply, Inc. The agreement, effective February 11, 2026, resolves claims that were part of a broader enforcement action filed in the Court of Common Pleas of Philadelphia County, Pennsylvania (Civil Action No. 250803198).
Background of the Lawsuit
The litigation, styled Agape Total Health Care Inc., et al. v. Golden Hour, LLC, et al., was initiated by Jushi’s subsidiaries as part of a wider effort to curb the sale of unregulated intoxicating hemp‑derived THC products in Pennsylvania. According to the company, certain wholesalers and smoke shops are marketing products that contain THC levels exceeding legal hemp limits while labeling them as “hemp.” These items are allegedly being distributed outside the state’s regulated medical marijuana framework, giving unlicensed operators an unfair economic advantage, shifting compliance costs to legitimate licensees, and posing potential risks to public health.
Jushi maintains that the proliferation of such under‑tested products undermines the integrity of state‑regulated cannabis markets and endangers consumer safety. The company’s press release notes that similar concerns have been highlighted by national and industry media outlets.
Details of the Settlement
The Settlement Agreement and Mutual Release with Revelry Supply, Inc. marks the first resolution achieved in the broader Pennsylvania action. While the financial terms of the settlement were not disclosed, Jushi emphasized that the agreement favourably resolves the claims asserted against Revelry and allows the company to continue pursuing its remaining defendants.
Trent Woloveck, Chief Strategy Director of Jushi, commented on the development:
“We initiated this litigation to help protect the integrity of state regulated cannabis markets and, most importantly, to support public health and safety by addressing the proliferation of under‑regulated intoxicating products being sold across the US. We believe consumers deserve transparency, product testing, and regulatory accountability. We will continue to shine the light on the bad actors in ‘hemp’. This first settlement marks an important step in that effort, and we remain committed to advocating for a fair, well‑regulated marketplace that protects patients, consumers, and stakeholders.”
Jushi’s Ongoing Commitment
Jushi Holdings Inc. is a vertically integrated, multi‑state cannabis operator that cultivates, manufactures, distributes, and retails cannabis products across several U.S. markets. The company states that it will continue to pursue its claims against the remaining defendants in Pennsylvania and, where appropriate, in other jurisdictions.
The press release includes standard forward‑looking statements cautioning readers that actual results may differ due to various risks, including market competition, regulatory changes, and litigation outcomes.
About Jushi Holdings Inc.
Jushi Holdings Inc. focuses on building best‑in‑class retail, cultivation, manufacturing, and distribution operations. The company operates in multiple U.S. states and is dedicated to delivering high‑quality cannabis products through its branded retail locations and cultivation and processing facilities.
For further information, please contact:
Jushi Investor Relations
Trent Woloveck
Co‑Chief Strategy Director
614‑271‑4349
trent@jushico.com
investors@jushico.com
Source: Here
